ARCHIVES

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

This article is from The Cancer Letter archive.

Vol. 04 No. 33 | August 18, 1978

Download PDF Visit The Full Archive

Related Articles

DCT Board reluctantly Okays Resources Contracts Recompetition, $6 of $10 Million Competitively

April 1, 1977

Mouse Strains Now Available From NCI

March 18, 1983

ACS Seeks Applications For Clinical Awards

January 1, 1993

Center Directors Solidly opposed To Core grant changes, Ask Upton, NCAB To Find Other Solutions

November 11, 1977

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

NCI Programs: Pediatric Brain Tumor Grants Awarded

April 16, 1999